Betapharm Arzneimittel GmbH
PolandAll drugs from this manufacturer
-
The medicine is used in adults to prevent the formation of blood clots after hip or knee replacement surgery, to prevent blood clots in the heart in people with an irregular heartbeat (atrial fibrillation), and to treat deep vein thrombosis and pulmonary embolism.
Dosage form: tablets, film-coated
Active substance Dosage apixaban 2.5 mg ATC: B01AF02
-
The medicine is used in adults to prevent the formation of blood clots in the heart (in people with atrial fibrillation and additional risk) and for the treatment and prevention of recurrence of blood clots in the veins of the lower limbs and in the blood vessels of the lungs.
Dosage form: tablets, film-coated
Active substance Dosage apixaban 5 mg ATC: B01AF02
-
This medicine is used in adults to prevent strokes and blood clots (in atrial fibrillation) and in the treatment and prevention of blood clots in the veins of the legs and lungs. In children, the medicine is used to treat and prevent recurrences of blood clots.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 150 mg ATC: B01AE07
-
The medicine is used in adults to prevent blood clots after hip or knee replacement surgery, to prevent strokes in people with atrial fibrillation, and to treat and prevent the recurrence of blood clots in the leg and lung veins. In children, the medicine is used to treat blood clots and to prevent their recurrence.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 110 mg ATC: B01AE07
-
In adults, this medicine is used to prevent the formation of blood clots in the veins after hip or knee replacement surgery. In children, it is used to treat blood clots and to prevent them from recurring.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 75 mg ATC: B01AE07
-
The medicine is used to support weight loss in adults (with obesity or overweight with comorbidities), adolescents, and children with obesity. It is used as an adjunct to diet and increased physical activity.
Dosage form: solution for injection in a syringe
Active substance Dosage liraglutide 6 mg/ml ATC: A10BJ02
-
The medicine is used in adults and children and adolescents (over 10 years of age) for the treatment of relapsing-remitting multiple sclerosis (MS), particularly in individuals for whom other treatments have not been effective or in whom the disease is progressing rapidly and severely.
Dosage form: capsules, hard
Active substance Dosage fingolimod hydrochloride 0.56 mg ATC: L04AA27
-
This medicine is used to treat postmenopausal women with a certain type of breast cancer (locally advanced or metastatic) that is hormone receptor-positive. It may also be used in combination with palbociclib in women with hormone receptor-positive breast cancer (without HER2 overexpression).
Dosage form: solution for injection in ampoule-syringe
Active substance Dosage fulvestrant 250 mg ATC: L02BA03
-
The medicine is used in adults for the treatment of advanced renal cell carcinoma (with metastases to other organs) and in certain types of soft tissue sarcoma.
Dosage form: tablets, film-coated
Active substance Dosage pazopanib hydrochloride No input provided ATC: L01EX03
-
The medicine is used in adults for the treatment of advanced or metastatic renal cell carcinoma and for the treatment of certain types of soft tissue sarcoma.
Dosage form: tablets, film-coated
Active substance Dosage pazopanib hydrochloride No input provided ATC: L01EX03
-
Polidia is used to support weight loss in adults, adolescents, and children with obesity or overweight (provided specific BMI and health criteria are met). It is used as an adjunct to diet and increased physical activity.
Dosage form: solution for injection in a syringe
Active substance Dosage liraglutide 6 mg/ml ATC: A10BJ02
-
The medicine is used in adults for the treatment of neuropathic pain (caused, for example, by diabetes or shingles), certain types of epilepsy, and generalized anxiety disorder.
Dosage form: capsules, hard
Active substance Dosage pregabalin 25 mg ATC: N03AX16
-
The medicine is used in adults for the treatment of neuropathic pain (resulting, for example, from diabetes or shingles), epilepsy (as an add-on to other anti-epileptic drugs), and generalized anxiety disorder.
Dosage form: capsules, hard
Active substance Dosage pregabalin 50 mg ATC: N03AX16
-
The medicine is used in adults for the treatment of neuropathic pain (resulting, for example, from diabetes or shingles), epilepsy (as an add-on to other anti-epileptic drugs), and generalized anxiety disorder.
Dosage form: capsules, hard
Active substance Dosage pregabalin 75 mg ATC: N03AX16
-
The medicine is used in adults for the treatment of long-term neuropathic pain (caused, for example, by diabetes or shingles), for the treatment of certain types of epilepsy, and for the treatment of generalized anxiety disorder.
Dosage form: capsules, hard
Active substance Dosage pregabalin 100 mg ATC: N03AX16
-
The medicine is used in adults for the treatment of neuropathic pain (resulting, for example, from diabetes or shingles), certain types of epilepsy, and generalized anxiety disorder.
Dosage form: capsules, hard
Active substance Dosage pregabalin 150 mg ATC: N03AX16
-
The medicine is used in adults for the treatment of neuropathic pain (caused, among others, by diabetes or shingles), certain types of epilepsy, and generalized anxiety disorder.
Dosage form: capsules, hard
Active substance Dosage pregabalin 200 mg ATC: N03AX16
-
The medicine is used in adults for the treatment of neuropathic pain (resulting, for example, from diabetes or shingles), epilepsy (as an add-on to other anti-epileptic drugs), and generalized anxiety disorder.
Dosage form: capsules, hard
Active substance Dosage pregabalin 225 mg ATC: N03AX16
-
The medicine is used in adults for the treatment of neuropathic pain (caused by nerve damage, e.g., in diabetes or shingles), certain types of epilepsy, and for the treatment of generalized anxiety disorder.
Dosage form: capsules, hard
Active substance Dosage pregabalin 300 mg ATC: N03AX16
-
The medicine is used in adults to reduce the risk of a subsequent heart attack or death from cardiovascular disease (in patients with acute coronary syndrome) and to reduce the risk of blood clots in people with coronary artery disease or peripheral artery disease.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 2.5 mg ATC: B01AF01
-
The medicine is used in adults to prevent the formation of blood clots in the veins following hip or knee replacement surgery. It is also used to treat deep vein thrombosis and pulmonary embolism, and to prevent their recurrence.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 10 mg ATC: B01AF01
-
This medicine is used in adults to prevent strokes and other blood clots in the blood vessels (in atrial fibrillation) and to treat and prevent blood clots in the veins of the legs and pulmonary vessels. In children and adolescents (weighing more than 30 kg), it is used to treat blood clots after initial injectable treatment.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 15 mg ATC: B01AF01
-
This medicine is used in adults to prevent strokes and other blood clots (e.g., in atrial fibrillation) and to treat and prevent blood clots in the leg veins and pulmonary vessels. In children and adolescents (weighing more than 30 kg), it is used to treat blood clots after initial injectable treatment.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 20 mg ATC: B01AF01
-
The medicine is used to accelerate the recovery of muscle function after surgery, so that the patient can breathe independently sooner. It works by binding specific muscle relaxants (rocuronium bromide or vecuronium bromide) that are administered during general anesthesia.
Dosage form: solution for injection
Active substance Dosage sodium sugammadex 108.8 mg/ml ATC: V03AB35
-
The medicine is used to treat idiopathic or hereditary pulmonary arterial hypertension (PAH) in patients with moderate symptom severity.
Dosage form: solution for infusion
Active substance Dosage treprostinil 1 mg/ml ATC: B01AC21
-
The medicine is used for the treatment of idiopathic or hereditary pulmonary arterial hypertension (PAH) in patients with moderate symptom severity.
Dosage form: solution for infusion
Active substance Dosage treprostinil 2.5 mg/ml ATC: B01AC21
-
The medicine is used to treat idiopathic or hereditary pulmonary arterial hypertension (PAH) in patients with moderate symptom severity.
Dosage form: solution for infusion
Active substance Dosage treprostinil 5 mg/ml ATC: B01AC21
-
The medicine is used to treat idiopathic or hereditary pulmonary arterial hypertension (PAH) in patients with moderate symptom severity.
Dosage form: solution for infusion
Active substance Dosage treprostinil 10 mg/ml ATC: B01AC21